Anti-CCL18/ AMAC-1/ AMAC1 functional antibody

Anti-CCL18/ AMAC-1/ AMAC1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CCL18/CCL18 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0743-Ab-1/ GM-Tg-hg-SE0743-Ab-2Anti-Human CCL18 monoclonal antibodyHuman
GM-Tg-rg-SE0743-Ab-1/ GM-Tg-rg-SE0743-Ab-2Anti-Rat CCL18 monoclonal antibodyRat
GM-Tg-mg-SE0743-Ab-1/ GM-Tg-mg-SE0743-Ab-2Anti-Mouse CCL18 monoclonal antibodyMouse
GM-Tg-cynog-SE0743-Ab-1/ GM-Tg-cynog-SE0743-Ab-2Anti-Cynomolgus/ Rhesus macaque CCL18 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0743-Ab-1/ GM-Tg-felg-SE0743-Ab-2Anti-Feline CCL18 monoclonal antibodyFeline
GM-Tg-cang-SE0743-Ab-1/ GM-Tg-cang-SE0743-Ab-2Anti-Canine CCL18 monoclonal antibodyCanine
GM-Tg-bovg-SE0743-Ab-1/ GM-Tg-bovg-SE0743-Ab-2Anti-Bovine CCL18 monoclonal antibodyBovine
GM-Tg-equg-SE0743-Ab-1/ GM-Tg-equg-SE0743-Ab-2Anti-Equine CCL18 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0743-Ab-1/ GM-Tg-hg-SE0743-Ab-2; GM-Tg-rg-SE0743-Ab-1/ GM-Tg-rg-SE0743-Ab-2;
GM-Tg-mg-SE0743-Ab-1/ GM-Tg-mg-SE0743-Ab-2; GM-Tg-cynog-SE0743-Ab-1/ GM-Tg-cynog-SE0743-Ab-2;
GM-Tg-felg-SE0743-Ab-1/ GM-Tg-felg-SE0743-Ab-2; GM-Tg-cang-SE0743-Ab-1/ GM-Tg-cang-SE0743-Ab-2;
GM-Tg-bovg-SE0743-Ab-1/ GM-Tg-bovg-SE0743-Ab-2; GM-Tg-equg-SE0743-Ab-1/ GM-Tg-equg-SE0743-Ab-2
Products NameAnti-CCL18 monoclonal antibody
Formatmab
Target NameCCL18
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CCL18 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0743-Ag-1Recombinant multi-species CCL18/ AMAC-1/ AMAC1 protein
    CytokineGM-Tg-g-SE0743-Ag-1chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) (CCL18) protein
    ORF Viral VectorvGMLP004613human CCL18 Lentivirus particle
    ORF Viral VectorpGMLP004613human CCL18 Lentivirus plasmid


    Target information

    Target IDGM-SE0743
    Target NameCCL18
    Gene ID6362,574181
    Gene Symbol and SynonymsAMAC-1,AMAC1,CCL18,CKb7,DC-CK1,DCCK1,MIP-4,PARC,SCYA18
    Uniprot AccessionP55774,Q8HYP8
    Uniprot Entry NameCCL18_HUMAN,CCL18_MACMU
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseaseProstate Cancer, Malignant neoplasm of bladder, Overactive bladder
    Gene EnsemblENSG00000275385
    Target ClassificationN/A

    The target: CCL18, gene name: CCL18, also named as AMAC-1, AMAC1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18. This antimicrobial gene is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 17. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for naive T cells, CD4+ and CD8+ T cells and nonactivated lymphocytes, but not for monocytes or granulocytes. This chemokine attracts naive T lymphocytes toward dendritic cells and activated macrophages in lymph nodes. It may play a role in both humoral and cell-mediated immunity responses. [provided by RefSeq, Sep 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.